Alejandro Garcia Carranca
Overview
Explore the profile of Alejandro Garcia Carranca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Cruz Lopez K, Toledo Guzman M, Sanchez E, Garcia Carranca A
Front Oncol
. 2020 Jan;
9:1373.
PMID: 31921637
Continuous proliferation of tumor cells requires constant adaptations of energy metabolism to rapidly fuel cell growth and division. This energetic adaptation often comprises deregulated glucose uptake and lactate production in...
2.
Galvan S, Garcia Carranca A, Song J, Recillas-Targa F
Front Genet
. 2015 Mar;
6:48.
PMID: 25788901
No abstract available.
3.
Lopez J, Valdez-Morales F, Benitez-Bribiesca L, Cerbon M, Garcia Carranca A
Reprod Biol Endocrinol
. 2013 Jun;
11:53.
PMID: 23782518
The female reproductive system (FRS) has a great capacity for regeneration. The existence of somatic stem cells (SSC) that are likely to reside in distinct tissue compartments of the FRS...
4.
Gissmann L, Garcia Carranca A
Arch Med Res
. 2009 Oct;
40(6):427.
PMID: 19853181
No abstract available.
5.
Cantu de Leon D, Perez-Montiel D, Villavicencio V, Garcia Carranca A, Betancourt A, Acuna-Alonzo V, et al.
BMC Cancer
. 2009 Feb;
9:48.
PMID: 19196481
Background: The development of breast cancer is multifactorial. Hormonal, environmental factors and genetic predisposition, among others, could interact in the presentation of breast carcinoma. Human leukocyte antigen (HLA) alleles play...
6.
Garcia Carranca A, Galvan S
Expert Rev Vaccines
. 2007 Aug;
6(4):497-510.
PMID: 17669005
Prophylactic vaccines against human papillomavirus (HPV) are on the market and will certainly reduce the incidence of genital warts and the risk of developing cervical cancer. In addition, they will...
7.
Sanchez J, Chavez Brambila J, Hernandez Hernandez D, Martinez Sanchez S, Garcia Carranca A
Ginecol Obstet Mex
. 2002 Mar;
70:11-6.
PMID: 11913045
Unlabelled: The objective of this study was to determine high risk human papillomavirus infection (HPV-RH) and factors with cervical intraepithelial neoplasia appears (CIN). Material And Method: From October 1998 to...